Genocea Biosciences Inc (OTCPK:GGNNQ)
$ 0.0005 0 (0%) Market Cap: - Enterprise Value: - PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Genocea Biosciences, Inc. - Special Call Transcript

Jun 03, 2019 / 12:30PM GMT
Operator

Good morning, and welcome to Genocea's GEN-009 ASCO Results Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.

At this time, I'd like to turn the call over to Dan Ferry of LifeSci Advisors. Please proceed.

Daniel Ferry
LifeSci Advisors, LLC - MD & Relationship Manager

Thank you, operator, and good morning, everyone. Earlier today, we issued a press release with some of the highlights on the GEN-009 clinical data presented at ASCO on Saturday morning. This release is available at genocea.com under the Investors tab.

During the call today, Chip Clark, Genocea's President and CEO; Dr. Jessica Flechtner, Genocea's Chief Scientific Officer; and Dr. Tom Davis, Genocea's Chief Medical Officer, will be discussing these results in detail with accompanying slides. After the prepared remarks, we will open up the call for Q&A.

Before we begin, I would like to remind everyone that statements made during this conference call relating to Genocea's expected future

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot